orforglipron and retatrutide Retatrutide vs Orforglipron: Efficacy vs Scalability in Diabetes Treatment According to The Conversation, a
Description
In several documented cases, patients did not experience skin sensitivity at lower starting doses
In the presence of high concentrations of glucose, GLP-1 interacts with GLP-1R, resulting in cyclin AMP (cAMP) formation14)
In studies, gastrointestinal side effects were more common in people taking Zepbound than people taking placebo, and people taking Zepbound were more likely than those on placebo to stop treatment because of these side effects
GLP-1 related nausea is rarely so bad that it causes concern
